Child Neurology Foundation Image
A Child Neurology Foundation Resource....
Creating a Community of Support
  

Happy New Year and welcome to the Child Neurology Foundation (CNF) e-newsletter. CNF's mission is to improve the lives of children living with neurologic disorders that each may reach his or her full potential. We work to achieve this daily by creating connections between patients and their families, physicians, other healthcare professionals, and industry and advocacy partners to improve quality of care and quality of life. Please visit our website to learn more by clicking on the icon below that most pertains to your role in the child neurology community. 

This quarter, we're bringing you information and resources on Creatine Transporter Deficiency (CTD) Syndrome and sharing incredible stories from families impacted by CTD. Regardless of your role in the community, these stories serve as inspiration and insight into caring for a child with a rare neurologic disorder. Please share this important content with your circle of influence and assist with CTD awareness!
I AM a patient or caregiver
I AM an advocate
I AM a provider or researcher
I AM a donor
Creatine Transporter Deficiency (CTD) Syndrome 

What is CTD and what are the symptoms?
CTD is an X-linked inherited disorder that primarily affects the brain. People with this disorder have intellectual disability, which can range from mild to severe, and delayed speech development. Some affected individuals develop behavioral disorders such as attention deficit hyperactivity disorder or autistic behaviors. They may also experience seizures. It is likely that CTD is the second most-common cause of X-linked mental retardation behind Fragile X.

What causes CTD?
Mutations in the SLC6A8 gene on the X chromosome cause CTD. The SLC6A8gene provides instructions for making a protein that transports the compound creatine into cells. Creatine is needed for the body to store and use energy properly. SLC6A8 gene mutations impair the ability of the transporter protein to bring creatine into cells, resulting in a creatine shortage (deficiency).

How is CTD Diagnosed?
The ultimate diagnosis is made with genetic analysis of the SLC6A8 gene. For novel (new) mutations which have not been previously described, reduced creatine in cultured fibroblasts obtained by a skin biopsy can also be used as a confirmatory diagnosis.

How is CTD treated?
Creatine Transporter Deficiency (CTD) has no currently accepted standard of care. Patients with epilepsy are treated with AEDs and other medications may be employed to treat behavioral problems.

For additional information, visit:

or

Genetics Home Reference page, a service of the U.S. National Library of Medicine: http://ghr.nlm.nih.gov/condition/x-linked-creatine-deficiency 
REID'S STORY
THE ROAD TO A DIAGNOSIS: A MOTHER'S INTUITION AND HOW ONE FAMILY NEVER GAVE UP

Parents have a sixth sense about their children. Call it a hunch, a gut feeling or a Mother's/Father's intuition, but it is real. I think as parents we feel like we have a responsibility to society to be logical and methodical. We don't like making assumptions based on a mere feeling, but instead want evidence to show proof and validation. After all, that's what we've been taught. It is a terrifying thing to come to the realization that there might be something      wrong with your child, but it's even worse not being able to prove it.

It's that gut feeling that pushed me to keep searching for a diagnosis for my then-2-year-old son, Reid. For me, and for so many others out there like me, the road to a diagnosis can be a long journey. It is tiring and it's easy to run out of gas. I found myself searching for something I KNEW was there, but without direction I was forced to pave my own way. I took wrongs turns, but I stayed the course because I couldn't give up. On my quest to uncover Reid's diagnosis, I heard it all. We were told our son was delayed, to put him in therapy and that he might grow out of "this." We heard words like cerebral palsy, autism and failure to thrive. It was that feeling inside that urged me forward. If Reid was all of those things, then I wanted to know why.

After visits with over 20 specialists and years of dead ends, we felt like we had exhausted our resources in the Austin area. I was determined to find a specialist who was progressive and who wouldn't just stick a label on Reid and wish him well. I wanted someone who would see Reid as a whole and not just treat his symptoms. I packed Reid in the car and we drove to Houston hoping that Texas Children's Hospital would have the answers. On that drive along Interstate-10 from Austin to Houston I wondered if I'd ever find a team who would champion this child. Three days later, on my drive back home to Austin, I was confident that Dr. Michelle Holick and Texas Children's Hospital were the champions I had been looking for.

After more than two years, Dr. Michelle Holick at Texas Children's Hospital diagnosed Reid with X-linked (SLC-6A8) Creatine Transporter Deficiency. While I listened to her tell me how our lives would never be the same, I felt relief that the road to a diagnosis had finally come to an end.  If I could tell parents one thing, I'd tell them to persevere. Listen to your intuition and follow that for as long as it takes. Just because it hasn't been found, doesn't mean it isn't there to find.

Today, Reid is four-years-old. He battles daily with muscular and movement disorders, global developmental delay, expressive language delay, mental retardation, autistic behaviors and seizures. Thanks to Dr. Holick, I know for certain that he will not grow out of "this". Reid will live a life of constant care. But, he will smile and play and love. He will infect us with his energy and bring us joy. He will meet milestones at his own pace and I'll continue to be there every step of the way.

To read "The Parker Family Story" and the "Trenton's Story," visit: 

In loving memory of Will Parker
null
Trenton
(CTD) Resources

Association for Creatine Deficiencies Website: www.creatineinfo.org
Association for Creatine Deficiencies Community Facebook Page: www.facebook.com/creatineinfo

The Association for Creatine Deficiencies is committed to providing patient, family and public education to advocate for early intervention through newborn screening, and to promote and fund medical research for treatments and cures for Creatine Deficiency Syndromes.


Baby's First Test Website: www.babysfirsttest.org

Baby's First Test houses the nation's newborn screening clearinghouse. The clearinghouse provides current educational and family support and services information, materials, and resources about newborn screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.

Orphanet Website: www.orpha.net

Orphanet is the reference portal for information on rare diseases and orphan drugs, for all audiences. Orphanet's aim is to help improve the diagnosis, care and treatment of patients with rare diseases.



Global Genes Website: globalgenes.org/
Global Genes Rare Disease Toolkits Website: globalgenes.org/toolkits/

Global Genes™  is one of the leading rare disease patient advocacy organizations in the world. The non-profit organization promotes the needs of the rare disease community under a unifying symbol of hope - the Blue Denim Genes Ribbon™. What began as a grassroots movement in 2009 , with just a few rare disease parent advocates and foundations , has since grown to over 500 global organizations.


Lumos Pharma Website: lumos-pharma.com

Lumos Pharma, based in Austin, Texas, is focused on developing novel therapies for patients with unmet medical needs in rare and neglected diseases. Lumos Pharma's lead compound, LUM001, is a novel treatment for the rare disease, Creatine Transporter Deficiency (CTD). LUM001 has been granted orphan status in the US and is in preclinical development in partnership with scientists at the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health, through its Therapeutic for Rare and Neglected Diseases program. This NCATS collaboration has helped advance the lead molecule LUM001 as a clinical candidate by generating the data needed to file an investigational new drug application with the Food and Drug Administration.
To connect with the child neurology community, please visit the Child Neurology Foundation's website. It serves as an educational portal for patients and caregivers. It also allows our advocacy and industry partners to get the word out about their own programs, educational materials, research studies, and many other initiatives aimed at serving the child neurology community. While there are many viable and trustworthy disease-specific organizations, the Child Neurology Foundation is in a unique position to serve the overarching needs of all members of the community. The website serves as a home within the child neurology community where members can be certain that the information they receive is credible, as all content is vetted by child neurologists. 
Our Disorder Directory allows visitors to learn from the experts with disease-specific articles written for caregivers by leading child neurologists. Accompanied by stories from families living with the same disorders as well as trusted resources, this growing directory serves as a starting point for caregivers seeking direction and guidance related to their child's unique situation.

We welcome feedback and seek to expand our partnerships. If you'd like your organization's information and/or resources listed on our website, please visit _______________ to read our website policy and submit the questionnaire for inclusion on the CNF website.

Respectfully,
Child Neurology Foundation